Exhibits
10-Q
from 10-Q
61 pages
10-Q
05/01/24
EX-10.1
from 10-Q
10 pages
CVS Pharmacy, Inc. Restrictive Covenant Agreement
05/01/24
EX-10.2
from 10-Q
13 pages
Whereas, the Board of Directors (The "Board") of CVS Health Corporation ("CVS" or the “Company”) Believes It Is Necessary and Desirable for the Company to Be Able to Rely Upon Executive to Continue Serving in Executive’s Position With the Company in the Event of a Pending or Actual Change in Control of CVS; Whereas, Executive Is Employed by CVS Pharmacy, Inc., a Subsidiary of CVS, and This Agreement Shall Not Alter Executive's Status as an Employee at Will; Now, Therefore, in Consideration of the Promises and Mutual Covenants Contained Herein and for Other Good and Valuable Consideration, the Receipt of Which Is Mutually Acknowledged, CVS and the Executive (Individually a "Party" and Together the "Parties”) Agree as Follows: 1. Definitions
05/01/24
EX-10.3
from 10-Q
103 pages
364-Day Term Loan Credit Agreement by and Among CVS Health Corporation, the Lenders Party Hereto, Barclays Bank PLC and Jpmorgan Chase Bank, N.A., as Co-Syndication Agents, Goldman Sachs Bank USA and Wells Fargo Bank, National Association, as Co-Documentation Agents, and Bank of America, N.A., as Administrative Agent Dated as of March 25, 2024 Bofa Securities, Inc., Barclays Bank PLC, Goldman Sachs Bank USA, Jpmorgan Chase Bank, N.A. and Wells Fargo Securities, LLC, as Joint Lead Arrangers and Joint Bookrunners
05/01/24
EX-15.1
from 10-Q
1 page
Letter re unaudited interim financial information
05/01/24
EX-31.1
from 10-Q
1 page
Management certification of annual or quarterly disclosure
05/01/24
EX-31.2
from 10-Q
1 page
Management certification of annual or quarterly disclosure
05/01/24
EX-32.1
from 10-Q
1 page
Management certification of financial report
05/01/24
EX-32.2
from 10-Q
1 page
Management certification of financial report
05/01/24
